Table 3.

Area Under The Curve for Symptom Measures During 14 Days Following Initiation of Study Medications by Asthma Predictive Index Status

	Area Under the Curve
	Montelukast	Budesonide	Conventional Therapy
Wheezing Score
API Positive	4.45 # (2.75, 6.14) n = 58	4.88 (3.33, 6.44) n = 54	6.64 (4.61, 8.67) n = 30
API Negative	3.97 (2.35, 5.59) n = 36	4.05 (2.47, 5.63) n = 42	5.97 (3.82, 8.13) n = 17
Trouble Breathing Score
API Positive	4.57 † (2.85, 6.30) n = 58	3.98 ‡ (2.40, 5.57) n = 54	7.65 (5.59, 9.72) n = 30
API Negative	4.14 (2.54, 5.73) n = 36	4.26 (2.71, 5.80) n = 42	5.94 (3.83, 8.04) n = 17
Interference with Activity Score
API Positive	3.84 * (2.09, 5.59) n = 58	4.69 ‡ (3.08, 6.29) n = 54	8.30 (6.21, 10.40) n = 30
API Negative	5.35 (3.49, 7.21) n = 36	5.27 (3.48, 7.05) n = 42	6.01 (3.57, 8.44) n = 17

^#p=0.049 vs. Conventional therapy

^†p=0.007 vs. Conventional therapy

^‡p=0.001 vs. Conventional therapy

^*p=0.025 API positive vs. API negative

Data are expressed as adjusted means (95% CI)